The abstract is read at the publisher; the summary is JClub's.
Exercise is endorsed by major oncology agencies as a supportive-care adjunct, and emerging exercise-oncology evidence is being synthesized for anticancer prevention and therapeutic outcomes.
- Why it matters: The field addresses whether exercise benefits extend beyond symptom relief to measurable cancer risk, post-diagnosis outcomes, and treatment-relevant biological changes.
- What they did: This Review synthesizes epidemiological links between exercise and primary cancer risk and post-diagnosis outcomes, then summarizes clinical trials testing structured exercise therapy on clinical endpoints and blood- and tissue-based biomarkers.
- The result: The work frames how exercise may reshape the host macroenvironment and distant or tumor microenvironments, supporting translational steps toward precision exercise oncology.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.